Krilogy Financial LLC Acquires New Holdings in ARK Genomic Revolution ETF $ARKG

Krilogy Financial LLC bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the third quarter, Holdings Channel reports. The fund bought 195,220 shares of the company’s stock, valued at approximately $5,806,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. NewEdge Advisors LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 49.4% during the first quarter. NewEdge Advisors LLC now owns 5,384 shares of the company’s stock worth $112,000 after purchasing an additional 1,780 shares during the period. Atria Wealth Solutions Inc. grew its position in shares of ARK Genomic Revolution ETF by 11.6% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 13,935 shares of the company’s stock valued at $348,000 after buying an additional 1,453 shares during the last quarter. Moran Wealth Management LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 2nd quarter valued at about $311,000. Private Wealth Asset Management LLC increased its stake in shares of ARK Genomic Revolution ETF by 70.0% in the second quarter. Private Wealth Asset Management LLC now owns 1,275 shares of the company’s stock valued at $31,000 after buying an additional 525 shares during the period. Finally, Mutual Advisors LLC bought a new position in shares of ARK Genomic Revolution ETF during the second quarter worth about $200,000.

ARK Genomic Revolution ETF Stock Up 0.2%

ARK Genomic Revolution ETF stock opened at $29.13 on Wednesday. The stock’s 50 day moving average is $30.63 and its 200 day moving average is $28.64. ARK Genomic Revolution ETF has a one year low of $17.50 and a one year high of $34.39.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.